Informational letter to healthcare professionals, Amiodarone: reminder of the risks of treatment and the need for patient monitoring and follow-up

22.12.2025 300 views

Інформаційний лист-звернення до спеціалістів системи охорони здоров’я, Аміодарон: нагадування про ризики лікування та необхідність моніторингу та спостереження за пацієнтомPDF · 267 КБ

Завантажити

Informational letter to healthcare professionals, Amiodarone: reminder of the risks of treatment and the need for patient monitoring and follow-up

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Informational letter to healthcare professionals, Amiodarone: reminder of the risks of treatment and the need for patient monitoring and follow-up

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration